Prevalence of yaws and syphilis in the Ashanti region of Ghana and occurrence of H. ducreyi, herpes simplex virus 1 and herpes simplex virus 2 in skin lesions associated with treponematoses.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2024
Historique:
received: 16 11 2023
accepted: 06 05 2024
medline: 22 5 2024
pubmed: 22 5 2024
entrez: 22 5 2024
Statut: epublish

Résumé

Yaws affects children in tropical regions, while syphilis primarily affects sexually active adults worldwide. Despite various campaigns towards the eradication of yaws and elimination of syphilis, these two diseases are still present in Ghana. The aetiological agents of both diseases, two Treponema pallidum subspecies, are genetically similar. This study aimed to assess the prevalence of these treponematoses and the occurrence of pathogens causing similar skin lesions in the Ashanti region of Ghana. A point-of-care test was used to determine the seroprevalence of the treponematoses. Both yaws and syphilis were identified in the Ashanti region of Ghana. Multiplex PCR was used to identify treponemes and other pathogens that cause similar skin lesions. The results indicated that the seroprevalences of T. pallidum in individuals with yaws-like and syphilis-like lesions were 17.2% and 10.8%, respectively. Multiplex PCR results showed that 9.1%, 1.8% and 0.9% of yaws-like lesions were positive for Haemophilus ducreyi, herpes simplex virus-1 (HSV-1) and T. pallidum respectively. Among syphilis-like lesions, 28.3% were positive for herpes simplex virus -2 (HSV-2) by PCR. To our knowledge, this is the first time HSV-I and HSV-2 have been reported from yaws-like and syphilis-like lesions, respectively, in Ghana. The presence of other organisms apart from T. pallidum in yaws-like and syphilis-like lesions could impede the total healing of these lesions and the full recovery of patients. This may complicate efforts to achieve yaws eradication by 2030 and the elimination of syphilis and warrants updated empirical treatment guidelines for skin ulcer diseases.

Identifiants

pubmed: 38776332
doi: 10.1371/journal.pone.0295088
pii: PONE-D-23-37271
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0295088

Informations de copyright

Copyright: © 2024 Boaitey et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

JBP reports research support from Gilead Sciences, non-financial support from Abbott Laboratories, and consulting for Zymeron Corporation, all outside the scope of this work. This does not alter our adherence to PLOS ONE policies on sharing data and materials. All other authors declare no com-peting interests.

Auteurs

Yaw Agyekum Boaitey (YA)

School of Life Sciences, University of Westminster, London, United Kingdom.
Komfo Anokye Teaching Hospital, Kumasi, Ghana.

Alex Owusu-Ofori (A)

Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Amarachukwu Anyogu (A)

School of Biomedical Sciences, University of West London, London, United Kingdom.

Farhang Aghakhanian (F)

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Natasha Arora (N)

Zurich Institute of Forensic Medicine, University of Zurich, Zurich, Switzerland.

Jonathan B Parr (JB)

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.

Philipp P Bosshard (PP)

University Hospital Zurich, University of Zurich, Zurich, Switzerland.

Saki Raheem (S)

School of Life Sciences, University of Westminster, London, United Kingdom.

Pascale Gerbault (P)

Department of Genetic and Evolution, Laboratory of Anthropology, Genetic and Population, University of Geneva, Genève, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH